drugset / Trial / NCT04096170

Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo

NCT04096170 ↗

Phase 4 Completed 16 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

We aim to study the impact of perioperative IV lidocaine on postoperative pain control in patients undergoing paraesophageal hernia repair. This is in the context of an established ERAS protocol. We wish to study the effect of IV Lidocaine on postoperative short and long-term outcomes, including patients' length of stay postoperative mortality, morbidity, and quality of life. We will compare this to our standard pain management.

Timeline

Start
2018-06-21
Primary completion
2024-04-24
Completion
2024-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications